The Government has officially issued Resolution No. 21/2026/NQ-CP, marking a significant shift in healthcare administration. This resolution focuses on streamlining... Read more
Category: Uncategorized
Drowning – Acute Oxygen Deprivation Due To Water Asphyxiation And Rapid Risk Of Brain Injury
Drowning is one of the most dangerous emergencies—but also one of the most misunderstood. it’s often silent, quick, and easy... Read more
Bridging the manager readiness gap for 2026 strategy
The success of any organizational strategy is determined at the managerial level, where abstract goals are translated into daily operations.... Read more
Boehringer reports 16.6% weight loss in phase 3 trial for survodutide
Boehringer Ingelheim has released topline data from its Synchronize-1 phase 3 study, revealing that its drug candidate survodutide led to... Read more
Eli Lilly enters $2.2 billion genomic alliance with Bezos-backed Profluent
Eli Lilly has forged a major partnership with Profluent to develop advanced gene-editing tools using artificial intelligence, aiming to address... Read more
Merck and Remepy form alliance to pioneer hybrid drug development
Merck KGaA has entered into a collaborative agreement with Remepy to develop integrated "hybrid drugs" that merge pharmacological treatments with... Read more
Gilead finalizes $7.8 billion purchase of Arcellx
Gilead Sciences has concluded its merger with Arcellx, a move designed to secure full rights to an investigational cell therapy... Read more
Cellares and Cabaletta Bio ink 10-year pact to automate cell therapy manufacturing
A milestone in automated autologous CAR-T production Cellares and Cabaletta Bio have formalized a 10-year commercial supply agreement, marking a... Read more
Kite Pharma optimizes manufacturing ahead of next-generation cell therapy approval
Leveraging operational insights to accelerate commercialization Following an initial phase of navigating capacity constraints and logistical hurdles in the CAR-T... Read more









